Physician profile
Catherine Nelson
NPI 1235622515
$4,336.13
in general payments reported to CMS, 2019-2025
42 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $826 · 2023: $800 · 2024: $742 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,711 · Consulting Fee: $175 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,710.86 |
| Consulting Fee | $175.00 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $791.86 | 2021-2025 | |
| Amgen INC. | $379.30 | 2022-2025 | Prolia, Otezla, Repatha |
| Novo Nordisk INC | $322.99 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $310.14 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $260.92 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $257.37 | 2021 | |
| Pfizer INC. | $252.89 | 2023-2025 | |
| Abbott Laboratories | $227.53 | 2022-2025 | Navitor, Freestyle Libre 3 |
| Lilly USA, LLC | $172.84 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $142.80 | 2022-2025 | Airsupra, Farxiga |
| Dexcom, INC. | $118.44 | 2023-2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $109.83 | 2022-2025 | Austedo, Ajovy |
| Mannkind Corporation | $100.02 | 2023 | V-Go |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.86 | 2022-2025 | Xifaxan |
| Amneal Pharmaceuticals LLC | $56.36 | 2022-2025 | Unithroid |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.